Valuation: genOway

Market Cap 22.87M 26.31M 21.35M 19.6M 36.95M 2.51B 37.6M 252M 98.59M 1.25B 98.83M 96.64M 4.12B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.58M 34.04M 27.62M 25.36M 47.81M 3.24B 48.64M 326M 128M 1.62B 128M 125M 5.34B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-0.81%
Current month+0.82%
1 month+1.65%
6 months+1.65%
Current year-9.23%
1 week 2.4
Extreme 2.4
2.49
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%0.00%-19.34%-34.57% 26.31M
-0.29%-0.25%-1.20%+13.35% 48.22B
-2.71%-2.99%+398.09%+472.12% 38.79B
-0.71%+9.45%+27.90%+7.89% 38.41B
-0.71%-3.72%+4.94%+52.45% 34.88B
-2.41%+1.96%+11.68%+38.17% 29.19B
-0.66%-2.73%+35.50%+122.17% 16B
-0.19%-3.93% - - 16.05B
+1.30%+0.15%+3.13%+16.46% 13.53B
-3.15%-6.14%-4.82%-36.90% 12.22B
Average -1.03%-0.68%+50.65%+72.35% 24.73B
Weighted average by Cap. -1.12%+0.15%+75.75%+103.47%

Financials

2024 2025
Net sales 27.53M 31.68M 25.7M 23.6M 44.49M 3.02B 45.27M 303M 119M 1.51B 119M 116M 4.97B 28.6M 32.91M 26.7M 24.51M 46.22M 3.14B 47.03M 315M 123M 1.56B 124M 121M 5.16B
Net income 1.83M 2.11M 1.71M 1.57M 2.96M 201M 3.01M 20.15M 7.89M 100M 7.91M 7.74M 330M 928K 1.07M 866K 795K 1.5M 102M 1.53M 10.21M 4M 50.74M 4.01M 3.92M 167M
Net Debt 623K 717K 582K 534K 1.01M 68.32M 1.02M 6.86M 2.69M 34.07M 2.69M 2.63M 112M 6.72M 7.73M 6.27M 5.76M 10.86M 737M 11.05M 73.96M 28.97M 367M 29.04M 28.39M 1.21B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-08-04 2.460 -0.81% 57
26-08-03 €2.480 +1.64% 5,561
26-07-31 €2.440 0.00% 5,588
26-07-30 €2.440 -1.61% 4,991
26-07-29 €2.480 +0.81% 199
  1. Stock Market
  2. Stocks
  3. ALGEN Stock